Browse
Explore conditions, clinical trials, and the organisations running them.
Up to: Lysosomal storage disease with skeletal involvement · GNPTAB-mucolipidosis
Mucolipidosis type II
Mucolipidosis II (MLII) is a slowly progressive lysosomal disorder characterized by growth retardation, skeletal abnormalities, facial dysmorphism, stiff skin, developmental delay and cardiomegaly.
This condition has no sub-types.